Taipei Exchange - Delayed Quote TWD

Advagene Biopharma Co., Ltd. (6709.TWO)

Compare
20.25
+0.05
+(0.25%)
At close: 2:32:23 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Mr. Yu-Shen Hsu Chairman & GM -- -- --
Mr. Chen Bryon Founder & Director -- -- --
Kuangdun Su Accounting Supervisor -- -- --
Frank Hsiao Executive Vice President -- -- --

Advagene Biopharma Co., Ltd.

No. 308, Neihu Road
6th Floor Section 1 Neihu District
Taipei, 114
Taiwan
886 2 2797 0073 https://www.advagene.com.tw
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
11

Description

Advagene Biopharma Co., Ltd. engages in the research and development of vaccine technology and related products in Taiwan. Its products in development include nasal spray influenza vaccine, allergy vaccines, and COVID-19 immunotherapy. The company is based in Taipei, Taiwan.

Corporate Governance

Advagene Biopharma Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers